APA (7th ed.) Citation

Tausch, E., Schneider, C., Robrecht, S., Zhang, C., Dolnik, A., Bloehdorn, J., . . . Stilgenbauer, S. (2020). Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood, 135(26), 2402-2412. https://doi.org/10.1182/blood.2019004492

Chicago Style (17th ed.) Citation

Tausch, Eugen, et al. "Prognostic and Predictive Impact of Genetic Markers in Patients with CLL Treated with Obinutuzumab and Venetoclax." Blood 135, no. 26 (2020): 2402-2412. https://doi.org/10.1182/blood.2019004492.

MLA (9th ed.) Citation

Tausch, Eugen, et al. "Prognostic and Predictive Impact of Genetic Markers in Patients with CLL Treated with Obinutuzumab and Venetoclax." Blood, vol. 135, no. 26, 2020, pp. 2402-2412, https://doi.org/10.1182/blood.2019004492.